eDesiderata®

Informed Investment in Electronic Resources

Please log in or sign up to access all resource details and interactive features

Resources A-Z

CRL gathers and provides information here about commercial and open access digital resources of interest to the CRL community.  This information is intended to inform library decisions on investment in electronic resources and related services.

+ Suggest New Resource

Active Filters:
Elsevier
Health and Life Sciences

C

Cell Press

Cell Press, an imprint of Elsevier, publishes biology research and reviews. Cell Press journals include the flagship journal Cell, Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, Chemistry & Biology, Cell Metabolism, Cell Host & Microbe and Cell Stem Cell.

Provider: Elsevier
Updated: Sep 13, 2013 10:04am

E

Embase

Biomedical research and clinical practice with a special focus on all aspects of drug discovery and development. Embase provides users with timely access to pharmacological and biomedical literature to keep them up to date with the latest scientific developments. It contains records from over 7,000 journals from over 70 countries, which are fully indexed. Over 18 million bibliographic records are included with over 2,000 new records being added each working day.

Provider: Elsevier
Updated: Sep 22, 2015 12:15pm

S

Scopus

Scopus is the largest abstract and citation database of peer-reviewed literature and quality web sources with smart tools to track, analyze and visualize research. Quick, easy and comprehensive, Sciverse Scopus provides superior support for the literature research process and is designed to find the information researchers need.

Provider: Elsevier
Updated: Sep 22, 2015 12:06pm


While CRL makes every effort to verify statements made herein, the opinions expressed and evaluative information provided here represent the considered viewpoints of individual librarians and specialists at CRL and in the CRL community.  They do not necessarily reflect the views of CRL management, its board, and/or its officers.